137 related articles for article (PubMed ID: 2670428)
1. Effect of erythropoietin administration in uremia.
Gurland HJ; Samtleben W; Schmidt B
Contrib Nephrol; 1989; 70():172-7. PubMed ID: 2670428
[No Abstract] [Full Text] [Related]
2. Acute effect of erythropoietin on endothelin release in uremia.
Nurol A; Bahattin A; Tolga K; Tekin A; Abdülkerim B
Nephron; 1996; 72(4):728-9. PubMed ID: 8730461
[No Abstract] [Full Text] [Related]
3. Recombinant human erythropoietin reduces free erythrocyte protoporphyrin levels in patients on chronic dialysis.
Piazza V; Villa G; Galli F; Segagni S; Bovio G; Poggio F; Picardi L; Salvadeo A
Nephron; 1992; 61(1):54-7. PubMed ID: 1528341
[TBL] [Abstract][Full Text] [Related]
4. Effects of the evening i.v. administration of erythropoietin in haemodialyzed patients.
Buemi M; Allegra A; Laganà A; Aloisi C; Privitera M; Morabito N; Frisina N
Riv Eur Sci Med Farmacol; 1993; 15(5-6):195-7. PubMed ID: 7761669
[TBL] [Abstract][Full Text] [Related]
5. Possible relation between restless legs and anaemia in renal dialysis patients.
Roger SD; Harris DC; Stewart JH
Lancet; 1991 Jun; 337(8756):1551. PubMed ID: 1675404
[No Abstract] [Full Text] [Related]
6. Impact of recombinant erythropoietin on sexual function in hemodialysis patients.
Schaefer RM; Kokot F; Heidland A
Contrib Nephrol; 1989; 76():273-81; discussion 281-2. PubMed ID: 2684527
[No Abstract] [Full Text] [Related]
7. Influence of erythropoietin treatment on endocrine abnormalities in haemodialyzed patients.
Kokot F; Wiecek A; Grzeszczak W; Klepacka J; Klin M; Lao M
Contrib Nephrol; 1989; 76():257-70; discussion 270-2. PubMed ID: 2582782
[No Abstract] [Full Text] [Related]
8. Erythropoietin for the anemia of chronic renal failure.
Schwartz AB; Prior J; Terzian L; Kahn B
Am Fam Physician; 1988 Jun; 37(6):211-5. PubMed ID: 3289343
[No Abstract] [Full Text] [Related]
9. [The effect of correcting anemia with recombinant erythropoietin on the central hemodynamic indices of patients on regular hemodialysis].
Ermolenko VM; Khvoĭnitskiĭ VA; Suprun EK; Tsukerman LI; Pokrovskiĭ IuA
Ter Arkh; 1992; 64(7):86-8. PubMed ID: 1440377
[No Abstract] [Full Text] [Related]
10. Anemia of hemodialysis patients: evaluation of the effect of BK-F polymethylmethacrylate membrane.
Locatelli F; Andrulli S; Del Vecchio L
Contrib Nephrol; 1999; 125():173-81. PubMed ID: 9895439
[No Abstract] [Full Text] [Related]
11. Identification of an erythropoietic inhibitor from the dialysate collected in the hemodialysis with PMMA membrane (BK-F).
Yamada S; Kataoka H; Kobayashi H; Ono T; Minakuchi J; Kawano Y
Contrib Nephrol; 1999; 125():159-72. PubMed ID: 9895438
[No Abstract] [Full Text] [Related]
12. L-Carnitine effects on anemia in uremic rats treated with erythropoietin.
Azzadin A; Wollny T; Pawlak R; Malyszko JS; Malyszko J; Myśliwiec M; Buczko W
Nephron; 1999; 83(4):370-1. PubMed ID: 10575305
[No Abstract] [Full Text] [Related]
13. Use of recombinant human erythropoietin (rh-EPO) in the treatment of anemia in hemodialysis patients: a multicenter Italian experience.
Buccianti G; Colombi L; Battistel V
Haematologica; 1993; 78(2):111-7. PubMed ID: 8349186
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and side effects of erythropoietin used in the treatment of anemia of uremic rats.
Gretz N; Lasserre J; Kraft K; Waldherr R; Weidler B; Meisinger E; Strauch M
Contrib Nephrol; 1988; 60():236-44. PubMed ID: 3345672
[No Abstract] [Full Text] [Related]
15. [New pathogenetic views on renal anemia].
Lamperi S
Minerva Nefrol; 1982; 29(2):61-70. PubMed ID: 6752763
[No Abstract] [Full Text] [Related]
16. The hematologic effect of androgen in uremic patients. Study of packed cell volume and erythropoietin responses.
Fried W; Jonasson O; Lang G; Schwartz F
Ann Intern Med; 1973 Dec; 79(6):823-7. PubMed ID: 4761909
[No Abstract] [Full Text] [Related]
17. rhEPO treatment of anemia in uremic patients.
Bommer J; Barth HP; Schwöbel B
Contrib Nephrol; 1990; 87():59-67. PubMed ID: 2093542
[No Abstract] [Full Text] [Related]
18. [Results of treating uremia anemia with human recombinant erythropoietin].
Litwin M; Grenda R; Jelonek A
Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):132-4. PubMed ID: 8090664
[TBL] [Abstract][Full Text] [Related]
19. When should we start erythropoietin therapy?
O'Riordan E; Foley RN
Nephrol Dial Transplant; 2001 May; 16(5):891-2. PubMed ID: 11328891
[No Abstract] [Full Text] [Related]
20. Recombinant human erythropoietin therapy. Part I: clinical issues.
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):1-34. PubMed ID: 2928605
[No Abstract] [Full Text] [Related]
[Next] [New Search]
